1,849
Views
16
CrossRef citations to date
0
Altmetric
Commentary

Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populations

, BA, , SM & , MD, MPH

References

  • Medley G, Lipari RN, Bose J, Cribb DS, Kroutil LA, McHenry G. Sexual Orientation and Estimates of Adult Substance Use and Mental Health: Results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review; October 2016.
  • De Pedro KT, Gilreath TD, Jackson C, Esqueda MC. Substance use among transgender students in California public middle and high schools. J School Health. 2017;87(5):303–309.
  • Rowe C, Santos G-M, McFarland W, Wilson EC. Prevalence and correlates of substance use among trans female youth ages 16-24 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015;147:160–166.
  • Nuttbrock L, Bockting W, Rosenblum A, et al. Gender abuse, depressive symptoms, and substance use among transgender women: a 3-year prospective study. Am J Public Health. 2014;104(11):2199–2206.
  • Green KE, Feinstein BA. Substance use in lesbian, gay, and bisexual populations: an update on empirical research and implications for treatment. Psychol Addict Behav. 2012;26(2):265–278.
  • Kerridge BT, Pickering RP, Saha TD, et al. Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States. Drug Alcohol Depend. 2017;170:82–92.
  • Institute of Medicine. The Health of Lesbian, Gay, Bisexual and Transgender People: Building a Foundation for Better Understanding. Committee on Lesbian, Gay Bisexual, and Transgender Health Issues and Research Gaps and Opportunities. Washington, DC: The National Academies Press; 2011.
  • Meyer IH. Minority stress and mental health in gay men. J Health Soc Behav. 1995;36(1):38–56.
  • Hatzenbuehler ML, Pachankis JE. Stigma and minority stress as social determinants of health among lesbian, gay, bisexual, and transgender youth: research evidence and clinical implications. Pediatr Clin North Am. 2016;63(6):985–997.
  • Goldbach JT, Tanner-Smith EE, Bagwell M, Dunlap S. Minority stress and substance use in sexual minority adolescents: a meta-analysis. Prev Sci. 2014;15(3):350–363.
  • Lehavot K, Simoni JM. The impact of minority stress on mental health and substance use among sexual minority women. J Consult Clin Psychol. 2011;79(2):159–170.
  • Keuroghlian AS, Reisner SL, White JM, Weiss RD. Substance use and treatment of substance use disorders in a community sample of transgender adults. Drug Alcohol Depend. 2015;152:139–146.
  • Gonzalez CA, Gallego JD, Bockting WO. Demographic characteristics, components of sexuality and gender, and minority stress and their associations to excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States. J Primary Prevent. 2017;38(4):419–445.
  • Friedman MS, Marshal MP, Guadamuz TE, et al. A meta-analysis of disparities in childhood sexual abuse, parental physical abuse, and peer victimization among sexual minority and sexual nonminority individuals. Am J Public Health. 2011;101(8):1481–1494.
  • Baams L. Disparities for LGBTQ and gender nonconforming adolescents. Pediatrics. 2018;141(5):e20173004.
  • Kecojevic A, Wong CF, Corliss HL, Lankenau SE. Risk factors for high levels of prescription drug misuse and illicit drug use among substance-using young men who have sex with men (YMSM). Drug Alcohol Depend. 2015;150:156–163.
  • Voisin DR, Hotton AL, Schneider JA, UConnect Study Team. The relationship between life stressors and drug and sexual behaviors among a population-based sample of young Black men who have sex with men in Chicago. AIDS Care. 2017;29(5):545–551.
  • Grant J, Mottet L, Tanis J, Harrison J, Herman J, Keisling M. Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Washington, DC: National Center for Transgender Equality and the National Gay and Lesbian Task Force; 2011.
  • Hotton AL, Garofalo R, Kuhns LM, Johnson AK. Substance use as a mediator of the relationship between life stress and sexual risk among young transgender women. AIDS Educ Prev. 2013;25(1):62–71.
  • Benotsch EG, Martin AM, Koester S, Cejka A, Luckman D. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sex Transm Dis. 2011;38(2):105–110.
  • Kelly BC, Parsons JT. Prescription drug misuse and sexual risk taking among HIV-negative MSM. AIDS Behav. 2013;17(3):926–930.
  • Zule WA, Oramasionwu C, Evon D, et al. Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users. Am J Drug Alcohol Abuse. 2016;42(6):689–697.
  • Jessell L, Mateu-Gelabert P, Guarino H, et al. Sexual violence in the context of drug use among young adult opioid users in New York City. J Interpers Violence. 2015;32(19):2929–2954.
  • Reback CJ, Fletcher JB. HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach. AIDS Behav. 2014;18(7):1359–1367.
  • Edelman EJ, Chantarat T, Caffrey S, et al. The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. Drug Alcohol Depend. 2014;139:79–85.
  • Dragon CN, Guerino P, Ewald E, Laffan AM. Transgender Medicare beneficiaries and chronic conditions: exploring fee-for-service claims data. LGBT Health. 2017;4(6):404–411.
  • American Society of Plastic Surgeons. Plastic Surgery Statistics Report. Arlington Heights, IL: American Society of Plastic Surgeons; May 2017. Available at: www.plasticsurgery.org/documents/News/Statistics/2016/plastic-surgery-statistics-full-report-2016.pdf. Accessed June 5, 2018.
  • Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.
  • Edlund MJ, Martin BC, Russo JE, et al. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–564.
  • Centers for Disease Control and Prevention (CDC). HIV Surveillance Report, 2016; vol. 28. Atlanta; 2017.
  • Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–222.
  • Parker R, Stein DJ, Jelsma J. Pain in people living with HIV/AIDS: a systematic review. JIAS. 2014;17(1):18719.
  • Uebelacker LA, Weisberg RB, Herman DS, Bailey GL, Pinkston-Camp MM, Stein MD. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med. 2015;16(10):1870–1881.
  • McCance-Katz EF, Sullivan L, Nallani S. Drug Interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010;19(1):4–16.
  • Jokinen V, Lilius T, Laitila J, et al. Do diuretics have antinociceptive actions: studies of spironolactone, eplerenone, furosemide and chlorothiazide, individually and with oxycodone and morphine. Basic Clin Pharmacol Toxicol. 2017;120(1):38–45.
  • Interactions with buprenorphine (suboxone) and antiretrovirals. HIV InSite: Database of Antiretroviral Drug Interactions. Available at: http://hivinsite.ucsf.edu/insite?page=ar-00-02&post=8&param=89 Accessed June 6, 2018.
  • McCance-Katz EF. Treatment of opioid dependence and coinfection with HIV and Hepatitis C virus in opioid- dependent patients: the importance of drug interactions between opioids and antiretroviral agents. Clin Infect Dis. 2005;41(Supplement_1):S89–S95.
  • Meier A, Lambert-Harris C, McGovern MP, Xie H, An M, McLeman B. Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. Am J Drug Alcohol Abuse. 2014;40(4):304–311.
  • Alessi EJ, Martin JI, Gyamerah A, Meyer IH. Prejudice-related events and traumatic stress among heterosexuals and lesbians, gay men and bisexuals. J Aggress Maltreat Trauma. 2013;22(5):510–526.
  • Reisner SL, White Hughto JM, Gamarel KE, Keuroghlian AS, Mizock L, Pachankis JE. Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults. J Couns Psychol. 2016;63(5):509–519.
  • Roberts NP, Roberts PA, Jones N, Bisson JI. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2015;38:25–38.
  • Institute of Medicine. Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. Washington, DC: National Academies Press; 2007.
  • Substance Abuse and Mental Health Services Administration. SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach. HHS Publication No. (SMA) 14-4884. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
  • Brezing C, Ferrara M, Freudenreich O. The syndemic illness of HIV and trauma: implications for a trauma-informed model of care. Psychosomatics. 2015;56(2):107–118.
  • Carroll K. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: National Institute on Drug Abuse; 1998.
  • Moore BA, Fiellin DA, Cutter CJ, et al. Cognitive behavioral therapy improves treatment outcomes for prescription opioid users in primary care buprenorphine treatment. J Subst Abuse Treat. 2016;71:54–57.
  • Lancaster CL, Teeters JB, Gros DF, Back SE. Posttraumatic stress disorder: overview of evidence-based assessment and treatment. JCM. 2016;5(11):105.
  • Resick PA, Galovski TE, Uhlmansiek MO, Scher CD, Clum GA, Young-Xu Y. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008;76(2):243–258.
  • Durvasula R, Miller TR. Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis. Behav Med. 2014;40(2):43–52.
  • Reback CJ, Shoptaw S. Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addict Behav. 2014;39(8):1286–1291.
  • Pachankis JE. A transdiagnostic minority stress treatment approach for gay and bisexual men’s syndemic health conditions. Arch Sex Behav. 2015;44(7):1843–1860.
  • Pachankis JE, Hatzenbuehler ML, Rendina HJ, Safren SA, Parsons JT. LGB-affirmative cognitive-behavioral therapy for young adult gay and bisexual men: a randomized controlled trial of a transdiagnostic minority stress approach. J Consult Clin Psychol. 2015;83(5):875–889.
  • Flentje A, Livingston NA, Roley J, Sorensen JL. Mental and physical health needs of lesbian, gay, and bisexual clients in substance abuse treatment. J Subst Abuse Treat. 2015;58:78–83.
  • Shim R, Rust G. Primary care, behavioral health, and public health: partners in reducing mental health stigma. Am J Public Health. 2013;103(5):774–776.
  • McGough PM, Bauer AM, Collins L, Dugdale DC. Integrating behavioral health into primary care. Popul Health Manag. 2016;19(2):81–87.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.